Adani Enterp. 2326.10↑370.05(18.92%)
Adani Ports 729.70↑41.60(6.05%)
Apollo Hospitals 4605.30↑158.15(3.56%)
Asian Paints 3084.90↑0.45(0.01%)
Axis Bank 917.55↓-6.50(-0.70%)
B P C L 361.60↑1.30(0.36%)
Bajaj Auto 4523.25↑40.05(0.89%)
Bajaj Finance 6793.05↑8.85(0.13%)
Bajaj Finserv 1413.00↓-2.10(-0.15%)
Bharti Airtel 801.85↓-3.90(-0.48%)
Britannia Inds. 4498.95↓-0.90(-0.02%)
Cipla 924.95↑8.70(0.95%)
Coal India 238.70↓-1.20(-0.50%)
Divi's Lab. 3265.00↑166.70(5.38%)
Dr Reddy's Labs 4457.65↑65.70(1.50%)
Eicher Motors 3545.45↓-25.45(-0.71%)
Grasim Inds 1718.35↑2.25(0.13%)
H D F C 2704.75↓-6.20(-0.23%)
HCL Technologies 1119.85↑24.50(2.24%)
HDFC Bank 1641.05↓-5.85(-0.36%)
HDFC Life Insur. 567.00↑9.40(1.69%)
Hero Motocorp 2692.15↓-20.85(-0.77%)
Hind. Unilever 2638.10↓-3.35(-0.13%)
Hindalco Inds. 407.70↑0.95(0.23%)
ICICI Bank 950.35↓-3.95(-0.41%)
IndusInd Bank 1246.15↓-1.85(-0.15%)
Infosys 1292.80↑23.90(1.88%)
ITC 424.75↑4.90(1.17%)
JSW Steel 704.60↑10.75(1.55%)
Kotak Mah. Bank 1940.20↓-1.45(-0.07%)
Larsen & Toubro 2216.60↑26.55(1.21%)
M & M 1265.55↑5.15(0.41%)
Maruti Suzuki 9156.65↑50.70(0.56%)
Nestle India 21494.80↓-195.35(-0.90%)
NTPC 174.10↑0.80(0.46%)
O N G C 165.60↑0.70(0.42%)
Power Grid Corpn 234.35↑0.65(0.28%)
Reliance Industr 2455.00↑13.05(0.53%)
SBI Life Insuran 1150.80↓-3.35(-0.29%)
St Bk of India 577.15↑2.00(0.35%)
Sun Pharma.Inds. 937.45↑11.60(1.25%)
Tata Consumer 766.10↑0.65(0.08%)
Tata Motors 522.50↓-2.45(-0.47%)
Tata Steel 105.00↑0.35(0.33%)
TCS 3298.70↑75.85(2.35%)
Tech Mahindra 1104.45↑32.30(3.01%)
Titan Company 2712.55↑10.90(0.40%)
UltraTech Cem. 7715.65↑34.35(0.45%)
UPL 670.40↑2.40(0.36%)
Wipro 395.75↑9.55(2.47%)

AI cannot replace human knowledge: Metropolis Healthcare Promoter & MD

In 2021-22, Covid19 business was almost 20-22% of the revenue for most diagnostic companies. The non-Covid19 business is not going to grow by 22% to make it equal

Sohini Das

Premium

Metropolis promoter and MD Ameera Shah

4 min read Last Updated : May 17 2023 | 9:34 PM IST

Listen to This Article

In 2021-22 (FY22), the Covid business was nearly 20-22 per cent of the revenue for most diagnostic companies. While non-Covid revenues have grown, they have not compensated for the loss felt earlier. AMEERA SHAH, promoter and managing director, Metropolis Healthcare, in conversation with Sohini Das, says that price hikes have begun in the sector. Edited excerpts:

Your non-Covid revenues have grown by about 9 per cent this quarter. But there is an overall drop in revenue in the fourth quarter (Q4) of 2022-23. Has the ‘Covid effect’ not normalised yet?

In FY22, the Covid business was nearly 20-22 per cent of the revenue for most diagnostic companies. The non-Covid business is not going to grow by 22 per cent to make it equal. For us, the non-Covid business has grown 18 per cent this year — this includes revenue from acquisition.